Join the laboratory of Dr. Shuguang Leng, PhD. This postdoctoral fellow will work closely with the principal investigator to develop several molecular and genomic epidemiological projects focusing on the understanding of cancer ethnic disparity and metal-induced health effects in multiethnic populations in the Southwestern United States. Specifically, the position will develop laboratory–based biomarker assays and genetic and genomic methods related to cancer that are applicable to human specimens for assessing specific hypotheses. Will also conduct bed- to benchside translational studies by performing independent research investigating the mechanisms underlying the associations observed at the population level. Successful candidate will have the opportunity to be involved in other key components of molecular epidemiological studies including biospecimen collection, processing and storage, primary data collection, development of analytical plans, and interpretation of epidemiological and genetic and genomic data.
This position requires a PhD in molecular epidemiology or a closely related field with strong practical experience in molecular or cellular biology and a proven record of peer-reviewed first-authorship publications. PhDs in biochemistry, molecular biology, or cell biology who have motivation to conduct translational research are strongly encouraged to apply. Candidate must have excellent work ethics, scientific integrity, and collaborative attitude.
Salary is commensurate with experience and is based upon the NIH Ruth Kirschenstein Postdoctoral Fellow Scale.
To apply, send a Curriculum Vitae, including a list of three references to Dr. Shuguang Leng using “application for a postdoctoral researcher position” on the subject line.
Shuguang Leng, PhD
Division of Epidemiology, Biostatistics, and Preventive Medicine
Department of Internal Medicine
UNM Comprehensive Cancer Center
Phone: (505) 272-9897
The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 500-mile radius. Its 124 board-certified oncology specialty physicians include cancer surgeons in every specialty (abdominal, thoracic, bone and soft tissue, neurosurgery, genitourinary, gynecology, and head and neck cancers), adult and pediatric hematologists/medical oncologists, gynecologic oncologists, and radiation oncologists. They, along with more than 600 other cancer healthcare professionals (nurses, pharmacists, nutritionists, navigators, psychologists and social workers), provide treatment to 65% of New Mexico’s cancer patients from all across the state and partner with community health systems statewide to provide cancer care closer to home. They treated 13,578 patients in 105,748 ambulatory clinic visits in addition to in-patient hospitalizations at UNM Hospital. A total of 1,610 patients participated in cancer clinical trials, including 696 patients who participated in clinical trials testing new cancer treatments that include tests of novel cancer prevention strategies and cancer genome sequencing. The 132 cancer research scientists affiliated with the UNMCCC were awarded $34.5 million in federal and private grants and contracts for cancer research projects and published 301 high quality publications. Promoting economic development, they filed more than 30 new patents since FY16, and since 2010, have launched 11 new biotechnology start-up companies. Scientists associated with the UNMCCC Cancer Control & Disparities have conducted more than 60 statewide community-based cancer education, prevention, screening, and behavioral intervention studies involving more than 10,000 New Mexicans. Finally, the physicians, scientists and staff have provided education and training experiences to more than 230 high school, undergraduate, graduate, and postdoctoral fellowship students in cancer research and cancer health care delivery.